Statement Of Preliminary Results To 31 March 2010 And Tradingf

Highlights of the preliminary results of Company to 31 March 2010 and to update shareholders on news of a new contract.

                                                                                                                                                 28 June 2010
                                                    SUTHERLAND HEALTH GROUP PLC
                                          (“Sutherland Health Group” or “the Company”)
                                                              PLUS Symbol: SHGP
STATEMENT OF PRELIMINARY RESULTS TO 31 MARCH 2010 AND TRADING                                 
UPDATE


The Board of Sutherland Health Group, a national supplier of patient hygiene, and sexual health products to customers including the NHS, are pleased to report on the highlights of the preliminary results of Company to 31 March 2010 and to update shareholders on news of a new contract.


PRELIMINARY RESULTS HIGHLIGHTS


• Sales growth of 6% to £956,509
• Gross Profit increased by 18% to £500,523
• Gross Margin increased from 46.9% to 52.3%
• Maiden profit of £29,336 (2009: loss of £81,912)


NEW CONTRACT


The Company has been awarded a contract by NHS England to supply its nutritional supplement Thixo-D® with effect from 1st May 2010 for a period of 12 months.


Thixo-D® is a nutritional supplement that is an instant food and drink thickener for the management of Dysphagia.


Dysphagia is a medical term that is used to refer to difficulties with swallowing certain foods or liquids or where patients are completely unable to swallow. It is estimated that 30 to 40 % of elderly people staying in nursing homes have some degree of dysphagia.


Thixo-D® is available on prescription and can also be purchased over the counter (OTC) from pharmacies.


Commenting Chairman John French said “I am delighted that the Company has achieved its maiden profit and I look forward to reporting on the full results in due course. The new contract for Thixo-D® will increase distribution of this important product and enables us to broaden our sales into the Nursing Home
sector as well as Hospitals”


                                                                         ---Ends---.


Enquiries:


John French, Chairman
Sutherland Health Group plc
E: john@sutherlandhealth.com
T: 07836 722 482


Bridge Hall
Alex Benger
E: corpfin@bhcf.co.uk
T: 020 7337 9705


Bishopsgate Communications Ltd.
Maxine Barnes
E: shg@bishopsgatecommunications.com
T: 020 7562 3367
 

Notes to Editors:

Sutherland Health Group Plc is a national supplier of patient hygiene, sexual health and diagnostic products to the UK National Health Service (NHS) and other UK customers. Its aim is to supply innovative solutions to current health issues by studying current trends and working alongside leading professionals who also work within the health sector.


The company is committed to developing and marketing high quality brands and products that will benefit health professionals and consumers alike in many areas of health. The Group has established its own brands Condomania® Condoms, Sutherland® Lubricating Jelly and Vision® pregnancy diagnostics that have already become established within the NHS business.


The Company has also developed the Sutherland® patient hygiene range which is now on contract with NHS England and NHS Northern Ireland that can reduce the risk to patients of cross infection.


The Group is ISO and MHRA registered, and at present principally operates within the United Kingdom.


For further information on the Company visit www.sutherlandhealth.com
 

Latest news RSS

09/11/2017

Sutherland at Procurex Wales 2017

Sutherland at Procurex Wales 2017

29/06/2017

Final Results 30th September 2016

Sutherland Health Group Final Results September 2016

11/11/2016

Sutherland Attending European Midwives Conference

Sutherland Attending EMA Conference

Sign up

Subscribe

For further information, please read our Privacy Policy.